Literature DB >> 22872792

Fertility Preservation Methods in Breast Cancer.

Fedro A Peccatori1, Lino Del Pup, Francesca Salvagno, Maurizio Guido, Maria A Sarno, Alberto Revelli, Luisa Delle Piane, Elisabetta Dolfin, Dorella Franchi, Emanuela Molinari, Valentina Immediata, Leonora Chiavari, Alessandra Vucetich, Andrea Borini.   

Abstract

Thanks to the recent advances in reproductive medicine, more and more young women with breast cancer may be offered the possibility of preserving their fertility. Fertility can be endangered by chemotherapy, by treatment duration and by patient's age at diagnosis. The currently available means to preserve a young woman's fertility are pharmacological protection with gonadotrophin-releasing hormone analogues during chemotherapy, and ovarian tissue or oocyte/embryo freezing before treatment. New future venues, including in vitro maturation, will improve the feasibility and efficacy of the fertility preservation methods in breast cancer patients.

Entities:  

Year:  2012        PMID: 22872792      PMCID: PMC3409388          DOI: 10.1159/000339671

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  62 in total

Review 1.  Vitrification as an alternative means of cryopreserving ovarian tissue.

Authors:  Christiani A Amorim; Mara Curaba; Anne Van Langendonckt; Marie-Madeleine Dolmans; Jacques Donnez
Journal:  Reprod Biomed Online       Date:  2011-05-07       Impact factor: 3.828

2.  Correlation of ovarian reserve tests with histologically determined primordial follicle number.

Authors:  Karl R Hansen; George M Hodnett; Nicholas Knowlton; LaTasha B Craig
Journal:  Fertil Steril       Date:  2010-06-01       Impact factor: 7.329

3.  Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.

Authors:  L Del Mastro; T Catzeddu; L Boni; C Bell; M R Sertoli; C Bighin; M Clavarezza; D Testa; M Venturini
Journal:  Ann Oncol       Date:  2005-10-27       Impact factor: 32.976

4.  Highly efficient vitrification method for cryopreservation of human oocytes.

Authors:  Masashige Kuwayama; Gábor Vajta; Osamu Kato; Stanley P Leibo
Journal:  Reprod Biomed Online       Date:  2005-09       Impact factor: 3.828

5.  Micro-organ ovarian transplantation enables pregnancy: a case report.

Authors:  Ariel Revel; Neri Laufer; Assaf Ben Meir; Meital Lebovich; Eduardo Mitrani
Journal:  Hum Reprod       Date:  2011-03-18       Impact factor: 6.918

6.  Birth following vitrification of a small number of human oocytes: case report.

Authors:  L Kuleshova; L Gianaroli; C Magli; A Ferraretti; A Trounson
Journal:  Hum Reprod       Date:  1999-12       Impact factor: 6.918

7.  Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program.

Authors:  Filippo Ubaldi; Reno Anniballo; Stefania Romano; Elena Baroni; Laura Albricci; Silvia Colamaria; Antonio Capalbo; Fabio Sapienza; Gábor Vajta; Laura Rienzi
Journal:  Hum Reprod       Date:  2010-02-25       Impact factor: 6.918

8.  Pregnancies and births after oocyte cryopreservation.

Authors:  Andrea Borini; Maria Antonietta Bonu; Giovanni Coticchio; Veronica Bianchi; Monica Cattoli; Carlo Flamigni
Journal:  Fertil Steril       Date:  2004-09       Impact factor: 7.329

Review 9.  Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.

Authors:  Michael von Wolff; Markus Montag; Ralf Dittrich; Dominik Denschlag; Frank Nawroth; Barbara Lawrenz
Journal:  Arch Gynecol Obstet       Date:  2011-03-24       Impact factor: 2.344

10.  Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women.

Authors:  Yvonne A R White; Dori C Woods; Yasushi Takai; Osamu Ishihara; Hiroyuki Seki; Jonathan L Tilly
Journal:  Nat Med       Date:  2012-02-26       Impact factor: 53.440

View more
  2 in total

1.  Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.

Authors:  Antonia Wenners; Jana Grambach; Juliane Koss; Nicolai Maass; Walter Jonat; Andreas Schmutzler; Christoph Mundhenke
Journal:  BMC Cancer       Date:  2017-09-06       Impact factor: 4.430

2.  In vitro maturation of immature oocytes for fertility preservation in cancer patients compared to control patients with fertility problems in an in vitro fertilization program.

Authors:  Irma Virant-Klun; Jure Bedenk; Nina Jancar
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.